Why Should I Vote On BetterDistricts?

Polling is a powerful tool to help our elected officials determine how they should vote.

Standard polling methods don't give you the control that you deserve. With BetterDistricts you can show your representative exactly how strongly a bill is supported in your community.

Send a clear signal on how you want your government to work.

 

S. 3711 - Opioid Treatment Surge Act

Sponsor: Jeff Merkley (D)
Introduced: 2018-12-05
Bill Status: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
 
Summary Not Available

Full Text


115th CONGRESS
2d Session
S. 3711


    To establish an annual fee applicable to opioid manufacturers.


IN THE SENATE OF THE UNITED STATES

December 5, 2018

    Mr. Merkley introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions


A BILL

    To establish an annual fee applicable to opioid manufacturers.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Opioid Treatment Surge Act”.

SEC. 2. Annual fee.

(a) In general.—For each of the 10 calendar years immediately proceeding the date of enactment of this Act, the Secretary of Health and Human Services shall assess a fee against each prescription drug manufacturer that, at any time during the period beginning on January 1, 1999, and ending on the calendar year immediately preceding the year in which the fee is assessed, manufactured any opioid drug (other than a drug described in subsection (b)). Such fee, with respect to such a manufacturer, shall be in an amount, as determined by such Secretary, that bears the same relationship to $2,000,000,000 as the market share of any such opioid drugs manufactured by such manufacturer during the period for which the fee is being assessed bears to the total market for opioid drugs (excluding such drugs described in subsection (b)) during such period.

(b) Exceptions.—The fee described in subsection (a) shall not apply with respect to any opioid drug used exclusively for the treatment of—

(1) opioid addiction, as part of a medically assisted treatment effort; or

(2) cancer or hospice patients.

(c) Transfers To block grant programs.—For each year that the Secretary of Health and Human Services assesses fees under subsection (a), the Secretary of the Treasury shall transfer from the general fund of the Treasury to the Secretary of Health and Human Services an amount equal to the amount of such fees, for purposes of carrying out the substance abuse prevention and treatment block grant under subpart II of part B of title XIX of the Public Health Service Act (42 U.S.C. 300x–21 et seq.).


Relevant News Stories And Blog Posts

Title Worth Reading

Vote on S. 3711

 

Activity in last 30 days